First international case rounds in the books!
Our first international case rounds was held on February 28th, 2023 with Dr. Marie Kostine as our featured researcher. Rounds were well attended by colleagues from across Canada, the United States and Europe.
Interesting discussions arose regarding differences in the biologic management of ICI-induced inflammatory arthritis which varies based on underlying malignancy in some centres. There is concern regarding use of TNF inhibitors in melanoma patients specifically in some centres managing these patients. Prescribing practices of biologics for the management of ICI-induced inflammatory arthritis differs across North America and Europe.
One of our attendees shared this article with us regarding risk of melanoma in patients treated with TNF inhibitors: https://www.canrio.ca/wp-admin/post.php?post=1205&action=edit&swcfpc=1